Clinical and therapeutic aspects of the antiphospholipid syndrome

Minocycline-induced arthritis.

Clinical and experimental rheumatology·1998

Therapeutic advances in systemic lupus erythematosus.

Current opinion in rheumatology·1998

Arterial disease in lupus and secondary antiphospholipid syndrome: association with anti-beta2-glycoprotein I antibodies but not with antibodies against oxidized low-density lipoprotein.

British journal of rheumatology·1998

Lack of cross-reaction between antibodies to beta2-glycoprotein-I and oxidized low-density lipoprotein in patients with antiphospholipid syndrome.

British journal of rheumatology·1998

Effects of human monoclonal anticardiolipin antibodies on platelet function and on tissue factor expression on monocytes.

Arthritis and rheumatism·1998

Binding of anticardiolipin antibodies to protein C via beta2-glycoprotein I (beta2-GPI): a possible mechanism in the inhibitory effect of antiphospholipid antibodies on the protein C system.

Clinical and experimental immunology·1998

High burden and unique pattern of cerebral small vessel disease in antiphospholipid syndrome: MRI subtypes and risk profile in a large cohort.

Lupus·2026

Association of serum levels of galectin-9 and IP-10 with disease activation in lupus nephritis.

Lupus·2026

Burden of herpes zoster and recombinant zoster vaccine willingness in systemic lupus erythematosus: A single-center cohort study.

Lupus·2026

Lupus nephritis at systemic lupus erythematosus onset and kidney outcomes in a Latin American biopsy-proven cohort.

Lupus·2026

Global prevalence and associated factors of metabolic syndrome in patients with systemic lupus erythematosus: A systematic review and meta-analysis.

Lupus·2026

Views on pregnancy and related concerns among women with systemic lupus erythematosus: A cross-sectional study.

Lupus·2026

Should we be monitoring patients on systemic dermatologic therapies for psychiatric adverse effects?: a proposed clinical framework.

The Journal of dermatological treatment·2026

Opioid Toxicity Associated With Tirzepatide in a Patient on Chronic Oral Morphine.

Cureus·2026

Observational characterization of self-reported SR-17018 exposure and outcomes in individuals with prior opioid use histories.

Frontiers in pharmacology·2026

Reconceptualizing Substance Use Disorders and Comorbidity: Moving Beyond Dual Diagnosis.

The Journal of nervous and mental disease·2026

Steered molecular dynamics and free-energy analysis of withanolide unbinding from tau kinases TTBK1 and GSK-3β.

Journal of biomolecular structure & dynamics·2026

Pain and Opioid Dose Reduction Based on Substance Use Disorder Status: Secondary Analysis from a Pragmatic Effectiveness Trial.

Journal of general internal medicine·2026

Related Experiment Videos

Clinical and therapeutic aspects of the antiphospholipid syndrome

Related Concept Videos

Minocycline-induced arthritis.

Therapeutic advances in systemic lupus erythematosus.

Arterial disease in lupus and secondary antiphospholipid syndrome: association with anti-beta2-glycoprotein I antibodies but not with antibodies against oxidized low-density lipoprotein.

Lack of cross-reaction between antibodies to beta2-glycoprotein-I and oxidized low-density lipoprotein in patients with antiphospholipid syndrome.

Effects of human monoclonal anticardiolipin antibodies on platelet function and on tissue factor expression on monocytes.

Binding of anticardiolipin antibodies to protein C via beta2-glycoprotein I (beta2-GPI): a possible mechanism in the inhibitory effect of antiphospholipid antibodies on the protein C system.

High burden and unique pattern of cerebral small vessel disease in antiphospholipid syndrome: MRI subtypes and risk profile in a large cohort.

Association of serum levels of galectin-9 and IP-10 with disease activation in lupus nephritis.

Burden of herpes zoster and recombinant zoster vaccine willingness in systemic lupus erythematosus: A single-center cohort study.

Lupus nephritis at systemic lupus erythematosus onset and kidney outcomes in a Latin American biopsy-proven cohort.

Global prevalence and associated factors of metabolic syndrome in patients with systemic lupus erythematosus: A systematic review and meta-analysis.

Views on pregnancy and related concerns among women with systemic lupus erythematosus: A cross-sectional study.

Should we be monitoring patients on systemic dermatologic therapies for psychiatric adverse effects?: a proposed clinical framework.

Opioid Toxicity Associated With Tirzepatide in a Patient on Chronic Oral Morphine.

Observational characterization of self-reported SR-17018 exposure and outcomes in individuals with prior opioid use histories.

Reconceptualizing Substance Use Disorders and Comorbidity: Moving Beyond Dual Diagnosis.

Steered molecular dynamics and free-energy analysis of withanolide unbinding from tau kinases TTBK1 and GSK-3β.

Pain and Opioid Dose Reduction Based on Substance Use Disorder Status: Secondary Analysis from a Pragmatic Effectiveness Trial.

Related Experiment Videos

Clinical and therapeutic aspects of the antiphospholipid syndrome

Related Concept Videos

Related Articles